|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
BHVN | Tilton John | Chief Commercial Officer | Jan 06 | Option Exercise | 0.00 | 1,250 | 0 | 4,955 | Jan 07 09:18 PM |
BHVN | Tilton John | Chief Commercial Officer | Jan 07 | Option Exercise | 0.00 | 875 | 0 | 5,279 | Jan 07 09:18 PM |
BHVN | Tilton John | Chief Commercial Officer | Nov 25 | Option Exercise | 0.00 | 1,250 | 0 | 3,909 | Nov 26 04:33 PM |
BHVN | Tilton John | Chief Commercial Officer | Jan 06 | Option Exercise | 0.00 | 1,250 | 0 | 3,151 | Jan 08 08:49 PM |
BHVN | Tilton John | Chief Commercial Officer | Nov 25 | Option Exercise | 0.00 | 1,250 | 0 | 2,020 | Nov 27 09:48 PM |
BHVN | Tilton John | Chief Commercial Officer | Jun 10 | Option Exercise | 9.29 | 52,000 | 483,080 | 52,770 | Jun 12 05:19 PM |
BHVN | Tilton John | Chief Commercial Officer | Jun 10 | Sale | 67.38 | 52,000 | 3,504,001 | 770 | Jun 12 05:19 PM |
BHVN | Tilton John | CCO-Rare & Neurologic Disorder | Dec 18 | Option Exercise | 0.00 | 1,250 | 0 | 1,250 | Dec 20 09:41 PM |
BHVN | Tilton John | Chief Commercial Officer | Mar 12 | Option Exercise | 9.29 | 10,000 | 92,900 | 10,000 | Mar 14 05:51 PM |
BHVN | Tilton John | Chief Commercial Officer | Mar 12 | Sale | 50.11 | 10,000 | 501,100 | 0 | Mar 14 05:51 PM |
BHVN | Tilton John | Chief Commercial Officer | Jan 10 | Option Exercise | 9.29 | 10,500 | 97,545 | 10,500 | Jan 14 05:50 PM |
BHVN | Tilton John | Chief Commercial Officer | Jan 10 | Sale | 37.67 | 10,500 | 395,535 | 0 | Jan 14 05:50 PM |
BHVN | Tilton John | Chief Commercial Officer | Nov 01 | Option Exercise | 9.29 | 30,000 | 278,700 | 30,000 | Nov 02 05:55 PM |
BHVN | Tilton John | Chief Commercial Officer | Nov 01 | Sale | 29.25 | 30,000 | 877,586 | 0 | Nov 02 05:55 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite